Clinical trial
Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast…
NCT00437853 · Instituto Nacional de Cancerologia de Mexico, Other · Completed
Key facts
| NCT number | NCT00437853 |
|---|---|
| Title | Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer |
| Lead sponsor | Instituto Nacional de Cancerologia de Mexico, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Anastrozole |
| Enrollment | 30 |
| Start date | Jun 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Feb 21, 2007 |
| Last update posted | Feb 21, 2007 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: